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 ABSTRACT | Objective: To compare the production of enzymes (proteinases and phospholipases) among the clinical and environ-
mental isolates of Cryptococcus neoformans, because researches with clinical and environmental isolates contribute to 
the understanding of the mechanisms involved in the control of these infections. Methods: In this research, 78 isolates 
of C. neoformans from clinical and environmental backgrounds were tested to demonstrate a possible associated phe-
notype and its virulence. Results: We observed that strains of clinical origin had a higher rate of phospholipase produc-
tion than those of proteinase. There was no such differentiation among strains of environmental origin. Conclusion: 
These aspects emphasize the role of phospholipase in cases of C. neoformans infections of clinical origin, and may be a 
marker to evidence these species.
 DESCRIPTORS | Cryptococcus; Cryptococcus neoformans; Enzymes; Virulence; Virulence Factors.
 RESUMO | Biossíntese de fosfolipases e proteinases usando cepas de origem clínica e de origem ambiental do complexo Cryptococ-
cus neoformans • Objetivo: Comparar a produção de enzimas (proteinases e fosfolipases) entre os isolados de origem clínica e de 
origem ambiental de Cryptococcus neoformans, uma vez que pesquisas com isolados de origem clínica e ambiental contribuem para a 
compreensão dos mecanismos envolvidos no controle destas infecções. Metodologia: Nesta pesquisa, 78 isolados de C. neoformans de 
origem clínica e ambiental foram testados para demonstrar um fenótipo possivelmente associado e sua virulência. Resultados: Obser-
vamos que as cepas de origem clínica tiveram uma taxa de produção de fosfolipase maior comparada à de proteinase. As cepas de origem 
ambiental não apresentaram tal diferenciação. Conclusão: Estes aspectos enfatizam o papel da fosfolipase em casos de infecções de C. 
neoformans de origem clínica e podem ser um marcador para evidenciar estas espécies.
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MATERIAL AND METHODS 
A total of 78 strains of C. neoformans were 
studied, of which 36 were of clinical origin 
isolated from cerebrospinal fluid of patients with 
meningitis, and 42 were of environmental origin 
isolated from pigeon feces. These samples are 
kept in a mycelium, in Sabouraud dextrose agar 
and mineral oil, in freeze-drying at -80 ° C in the 
Laboratory of Pathogenic Yeasts of the Department 
of Stomatology, Faculty of Dentistry, University of 
São Paulo.
The re-identification and confirmation of 
these strains were based on the methodology of 
Kurtzman, Fell9 and Kurtzman, Fell, Boekhout.10
The research of protease and phospholipase 
production was investigated in triplicate. The 
control strain producing these enzymes was C. 
albicans ICB-12A.
The technique proposed by Ruchel et al.11 was 
used to investigate the proteinase production. 
In each Petri dish containing the bovine serum 
albumin medium fraction V, only one strain was 
seeded. Seeding was done in the central part of 
the middle surface. The plates were incubated at 
32° C for up to 15 days. Proteinase production by 
the strain was verified by the presence of a clear 
zone of degradation around the colony (Figure 1). 
The proteolytic activity, called Pz, is expressed by 
calculating the ratio between the diameter of the 
colony (dc) and the diameter formed by the colony 
and the degradation zone (dcp).
For the phospholipase production tests, we 
used the technique proposed by Price et al.12 In 
each plate with culture medium, containing in 
the egg yolk composition, the sowing was done at 
a single central point on the surface of the culture 
medium. Plates were incubated at 32 ° C for up to 
15 days. Phospholipase-producing strains promote 
the formation of an area of opaque precipitation 
formed by calcium chloride around the colony 
(Figure 2). The value of phospholipase activity, 
INTRODUCTION 
The Cryptococcus pathogenic complex is 
composed of heterothallic encapsulated yeasts that 
form basidiospores under experimental conditions.1 
This pathogenic complex has two known species: 
Cryptococcus neoformans and Cryptococcus 
gattii. C. neoformans is the most frequent agent in 
cases of infection and mainly affects the face, neck 
and central nervous system.2,3 The lesions in the 
mouth appear as crateriform ulcers, which do not 
heal, with friable papillary erythematous plaques.3
Among the virulence factors already studied on 
C. neoformans, we can describe the production of 
enzymes, such as proteinase and phospholipase.4 
Proteinases are produced by bacteria, protozoa 
and fungi acting on the cycle of infection of these 
microorganisms. They also play a role in protein 
catabolism and may act in degradative pathways, 
peptide hormone release, blood coagulation, cell 
death, and tissue differentiation.5
Phospholipases are produced and secreted 
by a variety of pathogenic microorganisms as 
part of their virulence. From the five classes of 
phospholipases produced by microorganisms, 
the phospholipase B (PLB) and phospholipase C 
(PLC) have been implicated in the virulence of 
Cryptococcus sp.6,7
Due to the increase in the number of 
immunocompromised patients, it has been 
observed an increase in the incidence of fungal 
infections, such as cryptococcosis. Research 
with clinical and environmental isolates 
has contributed to the understanding of the 
mechanisms involved in the control of these 
infections.8 The objective of this study was to 
compare the production of enzymes (proteinases 
and phospholipases) between the clinical and 
environmental isolates of C. neoformans, to 
highlight a possible biological marker (phenotype) 
that would be more intrinsically connected to the 
virulence of this yeast.
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called Pz, was obtained by calculating the ratio 
between colony diameter (dc) and colony diameter 
and precipitation zone (dcp).
The results were analyzed based on index 3 
(strongly positive) for the enzyme phospholipase in 
clinical and environmental strains using the chi-
square statistical test of the BioEstat 5.0 program.
Figure 1 | Area of degradation of bovine serum albumin due to 
the action of the proteinase by the strain of C. neoformans.
Figure 2 | Calcium chloride precipitation zone due to phospholi-
pase by C. neoformans strain.
RESULTS 
After identification using biochemical and 
morphological methods, we observed that 36 
(46%) strains of clinical origin and 42 (54%) of 
environmental origin were from C. neoformans 
species.
In relation to the proteinase enzyme in the 
strains of clinical origin, 19.5% (7/36) had index 
3 (strongly positive), 50% (18/36) had index 2 
(positive) and 30.5% (11/36) had index 1 (negative). 
Regarding the phospholipase production, 89% 
(32/36) had index 3, 5.5% (2/36) had index 2 and 
5.5% (2/36) index 1 (Table 1).
Table 1 | C. neoformans strains of clinical origin relating produc-
tion index and virulence factors (proteinase and phospholipase).
Production index *
Virulence factors
Proteinase (%) Phospholipase (%)
3 19.5 89.0**
2 50.0 5.5
1 30.5 5.5
* Production index: (Pz = 1.0 = Absence of enzymatic activity – (Index: 
01); Pz ≥ 0.64 <1.0 = Positive Enzymatic activity (Index: 02); Pz <0.64 = 
Strongly positive activity – (Index: 03) 
** significant for p<0.05 – Chi-square test performed in the BioEstat 
5.0 program. 
Total number of strains: 36.
The strains of environmental origin, when 
studied in relation to proteinase production, 
showed that 38.1% (16/42) had index 3, 35.7% 
(15/42) had index 2 and 26.2% (11/42) had index 1. 
For phospholipase production, 52.4% (22/42) had 
index 3 and 47.6% (20/42) index 2 (Table 2).
Table 2 | C. neoformans strains of environmental origin relating pro-
duction index and virulence factors (proteinase and phospholipase).
Production index*
Virulence factors
Proteinase (%) Phospholipase (%)
3 38.1 52.4
2 35.7 47.6
1 26.2 -
* Production index: (Pz = 1.0 = Absence of enzymatic activity (Index: 01); 
Pz ≥ 0.64 <1.0 = Enzymatic activity positive  (Index: 02); Pz <0.64 = 
Strongly positive activity – (Index: 03).
Total number of strains: 42.
The statistical analysis of the results related 
to the index 3 (strongly positive) for the enzyme 
phospholipase between clinical and environmental 
strains was significant for the clinical strains 
(p <0.05).
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DISCUSSION 
In the investigation of proteinase production in 
strains of Cryptococcus neoformans, we obtained 
19.5% of strong positivity in clinical strains and 
38.1% of strong positivity in environmental strains.
Sánchez et al.,13 carrying out studies with 
clinical isolates of the National Institute of 
Health of Bogotá, classified the in vitro activity 
of proteinase production in C. neoformans into 
high, medium and non-producing. Most of the 
strains had medium to high proteolytic activity, 
corroborating with the findings of our research.
On the other hand, Baroni4 verified that none 
of the environmental isolates from pigeon feces 
were producers of the enzyme, thus disagreeing 
with the findings of our study. Pereira,14 studying 
the production of proteinase by strains from 
environmental isolates of poultry feces marketed in 
Pet Shops in Rio de Janeiro, found that 96% were 
strongly protease-producing.
Studies that compare proteinase production 
with clinical and environmental isolates of the 
Cryptococcus complex are rare. Regarding 
our findings, the higher productivity of 
protease (index 3 – strongly positive) due to 
the environmental strains can be explained by 
the protective role of this enzyme in adverse 
conditions of its ecological niche.
In this investigation, the production of 
phospholipase by strains of Cryptococcus 
neoformans was 88.9% with strong positivity in 
clinical strains, and 52.4% with strong positivity in 
environmental strains.
In the study conducted by Pereira,14 57.12% of 
the environmental isolates were strongly positive 
and came from poultry feces marketed in Pet Shops 
in Rio de Janeiro. Sánchez et al.13, studying the 
clinical origin of C. neoformans strains, classified 
the in vitro activity of the enzyme phospholipase 
into medium and high, and 68.6% of C. neoformans 
strains were classified with high activity.
Baroni4 found that 90.8% of strains isolated 
from pigeon feces were producers of phospholipase 
enzymes, 46% of which were strongly positive 
and 44.8% were positive. According to the author, 
considering the distribution of the different 
collection points of the samples, one must consider 
the possibility of risk of infection of passers-by and 
workers with these virulent strains.
Therefore, in this study, phospholipase was 
produced by the clinical and environmental 
strains and by the results of these two 
exoenzymes (proteinase and phospholipase), 
phospholipase was shown to be more important 
in the pathogenesis of cryptococcosis, because the 
percentage of the strongly positive index (89%) in 
clinical strains was higher than the environmental 
ones (52.4%).
According to Santagelo et al.15, the concentration 
of phospholipase B, lysophospholipase and 
lysophospholipase-transacylase produced by C. 
neoformans has an intrinsic relationship with 
virulence in mice.
In 2005, Santagelo et al.16 described for the 
first time the ELISA detection of antibodies to 
cryptococcal phospholipase B in serum of patients 
infected with C. neoformans and C. gattii. In this 
study, the authors provided the first confirmatory 
evidence of the in vitro production of cryptococcal 
phospholipase during human infection by C. 
neoformans and C. gattii.
CONCLUSION 
Although enzymes, protease and phospholipase, 
are present in the clinical and environmental 
strains of C. neoformans, the high production of 
phospholipase by clinical strains was prominent 
and statistically significant. The strongly positive 
production of the phospholipase enzyme by clinical 
strains of C. neoformans is a new parameter to be 
studied as a marker related to the greater virulence 
of this agent.
Cardoso PHM • Santos RLO • Souza AC • Baroni FA • Domaneschi C • Paula CR •
Clin Lab Res Den 2018: 1-5 ●  5
ACKNOWLEDGMENTS 
We thank Maria Catarina de Almeida Lago for 
assistance with translation; your comments greatly 
improved our manuscript.
REFERENCES 
1. Anaissie EJ, McGinnis MR, Pfaller MA. Clinical mycology. 
New York: Elsevier Health Sciences; 2009.
2. Lacaz CS, Porto E, Martins JEC, Heins-Vaccari EM, Melo 
NT. Tratado de micologia médica Lacaz. 9ª ed. São Paulo: 
Sarvier; 2002. 1104p.
3. Neville BW, Damm DD, Allen CM, Bouquot JE. Patologia oral 
e maxilofacial. 3ª ed. Rio de Janeiro: Elsevier; 2009. 972p.
4. Baroni FA. Ocorrência de Cryptococcus neoformans em ex-
cretas de pombos localizadas em torres de igrejas na cidade 
do Rio de Janeiro: fatores de virulência e sensibilidade aos 
antifúngicos [tese]. São Paulo: Instituto de Ciências Biológi-
cas da Universidade de São Paulo; 2001.
5. Calderone RA, Fonzi WA. Virulence factors of Candida al-
bicans. Trends Microbiol. 2001;9(7):327-35. doi: 10.1016/
S0966-842X(01)02094-7.
6. Ghannoum MA. Potential role of phospholipases in vi-
rulence and fungal pathogenesis. Clin Microbiol Rev. 
2000;13(1):122-43.
7. Siafakas AR, Wright LC, Sorrell TC, Djordjevic JT. Lipid 
rafts in Cryptococcus neoformans concentrate the virulen-
ce determinants phospholipase B1 and Cu/Zn superoxide 
dismutase. Eukaryot Cell. 2006;5(3):488-98. doi: 10.1128/
EC.5.3.488-498.2006.
8. Dias ALT, Brigagão MRPL, Colepicolo P, Siqueira AM, Sil-
va EG, Paula CR. Superoxide dismutase in Cryptococcus 
neoformans varieties gattii, grubii and neoformans. Mem 
Inst Oswaldo Cruz. 2006;101(1):107-9. doi: S0074-
02762006000100021.
9. Kurtzman CP, Fell JW. The yeasts: a taxonomic study. 4th 
ed. Amsterdam: Elsevier; 1998. 1076p.
10. Kurtzman CP, Fell JW, Boekhout T. The yeasts: a taxonomic 
study. 5th ed. Amsterdam: Elsevier; 2011. 2354p.
11. Rüchel R, Tegeler R, Trost M. A comparison of secretory pro-
teinases from different strains of Candida albicans. Sabou-
raudia. 1982;20(3):233-44.
12. Price MF, Wilkinson ID, Gentry LO. Plate method for detec-
tion of phospholipase activity in Candida albicans. Sabou-
raudia. 1982;20(1):7-14.
13. Sánchez A, Escandón P, Castañeda E. Determinación in vitro 
de la actividad de los factores asociados con la virulencia 
de aislamientos clínicos del complejo Cryptococcus neofor-
mans. Rev Iberoam Micol. 2008;25(3):145-9.
14. Pereira JR. Isolamento e caracterização de Cryptococcus 
neoformans de excretas de aves colhidas em lojas de animais 
do município do Rio de Janeiro [dissertação]. Rio de Janeiro: 
Instituto de Veterinária, Universidade Federal Rural do Rio 
de Janeiro; 2006.
15. Santangelo RT, Nouri-Sorkhabi MH, Sorrell TC, Cagney M, 
Chen SC, Kuchel PW, et al. Biochemical and functional charac-
terisation of secreted phospholipase activities from Cryptococ-
cus neoformans in their naturally occurring state. J Med Mi-
crobiol. 1999;48(8):731-40. doi: 10.1099/00222615-48-8-731.
16. Santangelo RT, Chen SC, Sorrell TC, Wright LC. Detection 
of antibodies to phospholipase B in patients infected with 
Cryptococcus neoformans by enzyme-linked immunosor-
bent assay (ELISA). Med Mycol. 2005;43(4):335-41.
